MedPath

Prospective randomized trial of clinical outcomes of angiography-based fractional flow reserve guidance versus wire-based fractional flow reserve guidance

Not Applicable
Conditions
coronary artery disease
Registration Number
JPRN-UMIN000049230
Lead Sponsor
Gifu Heart Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients for whom PCI is not appropriate 2)Patients with within 72 hours of acute coronary syndrome 3)Patients with severe bronchial asthma or chronic obstructive pulmonary disease 4)Patients with heart failure categorized as NYHA class III or IV 5)Patients with allergy to contrast media

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Revascularization rate based on angiography-derived fractional flow reserve compared to that based on fractional flow reserve
Secondary Outcome Measures
NameTimeMethod
Adverse events after one year(cardiac death, myocardial infarction, ischemia-driven revascularization, stroke, hospitalization due to heart failure) Costs of cardiac catheterization and revascularization Costs of adverse events
© Copyright 2025. All Rights Reserved by MedPath